Southeast Asset Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.35M Sell
15,519
-496
-3% -$130K 0.44% 34
2026
Q1
$4.27M Buy
16,015
+1,275
+9% +$345K 0.47% 36
2025
Q4
$3.7M Buy
14,740
+2,601
+21% +$691K 0.35% 49
2025
Q3
$3.48M Sell
12,139
-291
-2% -$78K 0.38% 44
2025
Q2
$3.26M Buy
12,430
+84
+0.7% +$20.5K 0.39% 45
2025
Q1
$2.87M Buy
12,346
+4,020
+48% +$976K 0.35% 43
2024
Q4
$1.91M Buy
+8,326
New +$1.91M 0.23% 61

Other funds holding LH

Southeast Asset Advisors's LH Position: Q2 2026 in Review

Southeast Asset Advisors reduced its Labcorp (LH) stake by 3.1% in Q2 2026, selling an estimated $130K and leaving 15,519 shares worth $4.35M. The position accounts for 0.44% of the portfolio, ranked #34.

Southeast Asset Advisors first reported a position in LH in Q4 2024 and has held it in 7 quarters since. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Southeast Asset Advisors held 15,519 shares of Labcorp worth $4.35M as of Q2 2026.
  • Southeast Asset Advisors sold 496 Labcorp shares in Q2 2026, an estimated $130K.
  • Labcorp made up 0.44% of Southeast Asset Advisors's portfolio in Q2 2026, its #34 holding.
  • Southeast Asset Advisors first reported a position in Labcorp in Q4 2024 and has held it in 7 quarters since.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Southeast Asset Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.